Citation tools
"Safety and effectiveness of Lutetium-177–Prostate-Specific Membrane Antigen in patients with metastatic castration-resistant prostate cancer with and without visceral metastases who had received prior radium-223: a post hoc analysis of the RALU study." Journal of Nuclear Medicine
64.supplement 1
(2023):
P607.
Web. 30 April. 2025.